
High CR Rate with Cretostimogene for BCG-Failed Bladder Cancer
Intravesical cretostimogene grenadenorepvec (CG0070) was highly effective and well tolerated in patients with high-risk Bacillus Calmette Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), according to data …